{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 7,
  "pageCount": 366,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a highly critical, investigative tone, framing the company as fraudulent and the drug as dangerous.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/7",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-7",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Harmony Biosciences is a house of cards, built on an extensive scientific, clinical, and commercial fraud designed to exploit every weak link in the US healthcare system.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9cc8-bb5ce103c3c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.52
      },
      "kind": "paragraph",
      "text": "A dangerous molecule in a drug class plagued by toxicity and FDA recalls. Histamine receptor antagonists like pitolisant have a uniquely risky molecular structure with a long history of cardiotoxicity and FDA recalls.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa3e9c4c-ee61-41bd-a59c-2a6564453c09",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.76
      },
      "kind": "paragraph",
      "text": "Pitolisant’s origin: an old, failed compound no reputable drug company would touch. Pitolisant was first synthesized a quarter-century ago, with a long and twisted history of failure.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbdd6dc5-31a5-4f04-a599-32a8e09db6e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Introduction to the real Harmony Biosciences. Harmony Biosciences is a house of cards, built on an extensive scientific, clinical, and commercial fraud designed to exploit every weak link in the US healthcare system.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fde26bbd-41e1-49da-a09b-cfb0433e9a4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.86,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Part 1. Pitolisant’s troubled history: an old, failed compound no reputable pharma company would touch; an inherently dangerous molecule in a class plagued by safety problems and recalls.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af6c1c82-2eeb-4535-aca5-92d457949c2e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.28,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Executive summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8320cf96-9214-4cbb-845a-148f92ff74fe",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "abd73b24-c076-4e1e-a02f-90dac949c060",
      "evidence": "title/action-title: Part 1. Pitolisant’s troubled history: an old, failed compound no reputable pharma company would touch; an inherently dangerous molecule in a class plagued by safety problems and recalls.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 1,
      "beatId": "aac0dd07-d17f-4430-b8ac-8dd57ce646ce",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Setup & Stakes",
      "beatSlug": null,
      "evidence": "The document sets up the stakes by presenting the company's troubled history and the concerns over its drug and financial reporting",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}